Drug Approval | September 16, 2021
Lancet study confirms Johnson & Johnson Ebola vaccine safe
Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses
_256_275.jpg)